硫堇相关的专利数据

序号	专利名	申请号	申请日	公开（公告）号	公开（公告）日	发明人
41	Isothioindigo-based polymers	US13359590	2012-01-27	US08613870B2	2013-12-24	Anthony James Wigglesworth; Yiliang Wu; Ping Liu
A polymer of Formula (I) wherein Ar, Y, Z, R3, R4, k, m, x, and n are as described herein. The isothioindigo-based polymer may be used in a semiconducting layer of an electronic device.
42	Thionin stain technique	EP90125587.7	1990-12-27	EP0445434B1	1997-11-05	Zahniser, David J.; Oud, Petrus S.

43	Thiobis(thioformate) containing photoconductors	US12212091	2008-09-17	US08053150B2	2011-11-08	Jin Wu
A photoconductor that includes, for example, a supporting substrate, a photogenerating layer, and a thiobis(thioformate) containing charge transport layer; a thiobis(thioformate) containing photogenerating layer, or where both at least one charge transport layer and the photogenerating layer includes, in addition to other components, a thiobis(thioformate).
44	Thiosteroid and process for producing the same	US30664739	1939-11-29	US2260953A	1941-10-28	RUDOLPH REBOLD

45	Method of preparing organic thionitrites	US33873640	1940-06-04	US2325391A	1943-07-27	GEORGE RICHARD S; CRANDALL GEORGE S; NYGAARD EDWIN M

46	Method for stabilizing organic thionitrites	US42459941	1941-12-27	US2328711A	1943-09-07	CRANDALL GEORGE S; GEORGE RICHARD S; NYGAARD EDWIN M

47	Tilting furnace for smelting pyrites and sulfur ores.	US1913760654	1913-04-12	US1075214A	1913-10-07	KNUDSEN EMIL

48	Oxidative hydrolysis of heteroaromatic thiones	US09970387	2001-10-02	US06472535B1	2002-10-29	David T. Erdman
A process for preparing a triazolinone includes the step of reacting a triazolinethione with an oxidant at a temperature range of from about 60° C. to about 100° C. in the presence of a base.
49	Thiazolidine-dione-thiones	US31091863	1963-09-23	US3256292A	1966-06-14	STOFFEL PAUL J

50	Thioninium compounds and their use	EP14185157.6	2007-03-28	EP2853293B1	2017-11-22	Wischik, Claude Michel; Rickard, Janet Elizabeth; Harrington, Charles Robert; Horsley, David; Storey, John Mervyn David; Marshall, Colin; Sinclair, James Peter
This invention pertains generally to processes, uses, methods and materials utilising particular diaminophenothiazinium compounds, specifically, ETC, DEMTC, DMETC, DEETC, MTZ, ETZ, MTI, MTI.HL, ETI, ETI.HL, MTN, and ETN. These compounds are useful as drugs, for example, in the treatment of tauopathies, such as Alzheimer's disease.
51	Hydrocarbon thiophosphoric acid salts of thialdine and certain homologues	US10074149	1949-06-22	US2610182A	1952-09-09	MCDERMOTT JOHN P

52	Thioninium compounds and their use	EP14185157.6	2007-03-28	EP2853293A1	2015-04-01	Wischik, Claude Michel; Rickard, Janet Elizabeth; Harrington, Charles Robert; Horsley, David; Storey, John Mervyn David; Marshall, Colin; Sinclair, James Peter
This invention pertains generally to processes, uses, methods and materials utilising particular diaminophenothiazinium compounds, specifically, ETC, DEMTC, DMETC, DEETC, MTZ, ETZ, MTI, MTI.HL, ETI, ETI.HL, MTN, and ETN. These compounds are useful as drugs, for example, in the treatment of tauopathies, such as Alzheimer's disease.
53	Silver halide emulsions containing hexathiocane thiones as sensitizers	US751585	1976-12-17	US4054457A	1977-10-18	John Howard Bigelow
Photographic silver halide emulsions are prepared which have their sensitivity increased by the addition of hexathiocane thiones having the basic structure: ##STR1## where R is an alkyl, unsaturated alkyl, or a saturated cyclic group, and R.sub.1 is aryl or substituted aryl.
54	결정질 메틸티오니늄 클로라이드（메틸렌 블루） 수화물	KR1020177013764	2010-09-23	KR1020170061177A	2017-06-02	힐피커롤프; 라거티모
본원에메틸티오니늄클로라이드의 3종의 2수화물 B형, C형및 D형및 1수화물 E형이기재되어있다. B형, C형, D형및 E형을더 높은수분함량을갖는메틸티오니늄클로라이드로부터또는수화물의전환으로부터제어습도및 온도하에제조할수 있다. 수화물을약학조성물에도입할수 있다.
55	THIONIN AS AN ANTINEOPLASTIC AND IMMUNOSTIMULANT	EP00964966	2000-09-11	EP1322323A4	2004-07-28	VERNON LEO P

56	THIONIN AS AN ANTINEOPLASTIC AND IMMUNOSTIMULANT	EP00964966.6	2000-09-11	EP1322323A1	2003-07-02	VERNON, Leo, P.
The invention involves cellular and biological responses to relatively low concentrations of thionin (such as Pyrularia thionin), which responses are distinct form the direct cytotoxic effect of high concentrations of thionins on cells. These two separate biological responses of immune cells to thionins are related to the presence of two separate and distinct binding sites on the immune cell, a high affinity binding site that reacts with thionins at low concentrations to stimulate the immune cell to provide antitumor protection, and a low affinity site that is responsible for the direct toxicity of thionins to cells. This invnetion provides, in certain embodiments, methods for usinga thionin, either alone or in combination with an interleukin, for stimulation of the immune system. Particular embodiments provide methods for inhibition of tumor formation and/or tumor metastasis, methods for the stimulation of natural killer cells, methods for the stimulation of T cell lymphocyte differentiation and proliferation, and/or methods for the stimulation of cytokine production by various immune cells. Also provided are compositions that include thionin, e.g., Pyrularia thionin, for the treatment and/or prevention of neoplasia, for the treatment of viral infection, for the treatment of immune deficiency e.g., such as is caused by disease or advancing age). Other embodiments of the invention provide biologically active compounds conjugated or otherwise complexed to the very stable thionin molecule (such as a βME-thionin conjugate), and methods of use of such compounds and/or conjugates for immunostimulation.
57	Preparation of cadmium selenide sulfide powder for electrophotography	JP3178783	1983-03-01	JPS59162109A	1984-09-13	SUMINO FUMIO
PURPOSE: To obtain the titled uniform powder having high crystallizability and narrow particle size distribution, by blending an aqueous solution of Cd salt with an S source and an Se source, emulsifying them in an organic solvent, reacting them under heating to give powder, blending the powder with a flux, calcining the blend. CONSTITUTION: An aqueous solution of Cd ²⁺ ion optionally containing ions of impurities such as Cu ²⁺, In ³⁺, Cl ^-, etc. is blended with a sulfur source (e.g., thiourea, etc.) capable of evolving H ₂S by heating and a selenium source evolving H ₂Se, the aqueous solution is emulsifying with a surface active agent (e.g., nonionic surface active agent such as sorbitan ester, etc.) in an organic solvent (e.g., xylene, etc.), and reacted under heating to give CdS.CdSe mixed powder. This mixture is blended with 20W65wt% flux (e.g., CdCl ₂, etc.), calcined primarily at a temperature ≥50°C higher than the melting point of the flux, and calcined secondarily at a temperature lower than it. The titled uniform powder having high crystallizability and narrow particle size distribution is prepared. COPYRIGHT: (C)1984,JPO&Japio
58	Thiopyrane-4-ones as DNA protein kinase inhibitors	US10486811	2002-08-14	US07105518B2	2006-09-12	Niall Morrison Barr Martin; Graeme Cameron Murray Smith; Roger John Griffin; Bernard Thomas Golding; Ian Robert Hardcastle; Laurent Jean Martin Rigoreau; David Richard Newell; Hilary Alan Calvert; Nicola Jane Curtin; Paul Workman; Florence Irene Raynaud; Bernard Paul Nutley
The present invention provides compounds of formula (I) and isomers, salts, solvates, chemically protected forms, and prodrugs thereof, wherein R1 and R2 are independently hydrogen, an option ally substituted C1-7 alkyl group, C3-20 heterocyclyl group, or C5-20 aryl group, or may together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms; and R3 is an optionally substituted C3-20 heterocyclyl or C5-20 aryl group, and their use as pharmaceuticals, particularly in treating diseases which are retroviral mediated or ameliorated by the inhibition of DNA-PK,
59	PERSONAL CARE COMPOSITIONS COMPRISING A PYRITHIONE AND AN IRON CHELATOR	EP11781931.8	2011-10-28	EP2632470B1	2018-02-28	SCHWARTZ, James, Robert; SAUNDERS, Charles, Winston; YOUNGQUIST, Robert, Scott; KELLY, Casey, Patrick; DOMSIC, Jeffrey, Kenneth; LUCAS, Robie, Lynn; XU, Jun
The present invention is directed to a personal care composition comprising an effective amount of a pyrithione or a polyvalent metal salt of a pyrithione; an effective amount of an iron chelator or a material which chelates iron; wherein the combination of the iron chelator and the pyrithione or a polyvalent metal salt of a pyrithione has a fractional inhibitor concentration of less than or equal to 1.
60	FORMULACIÓN DE CEMENTO EN BASE A SULFATOALUMINIO CON PROPORCIÓN PARTICULAR DE SISTEMAS YELEMÍTICOS	PCT/IB2015/059335	2015-12-03	WO2016088083A1	2016-06-09	TOBÓN, Jorge Iván; GIRALDO TORRES, Carolina; BERRIO SOLARTE, Ariel; LONDOÑO ZULUAGA, Diana
La presente invención corresponde a una formulación de cemento en base a base sulfoaluminato que comprende una proporción específica de cristales de Yeelemita que presenta propiedades de resistencia mecánica, fraguado y emisiones de CO2 mejoradas. Se describe también un concreto obtenido al mezclar dicha formulación con agua y yeso, que presenta un desempeño a edades iniciales mayor en comparación al concreto obtenido a partir de cemento Portland.

1 2 3 4 5 6 7 8 9 10

IPRDB

热门服务

关于我们

友情链接

联系方式